Rubicon Research

Rubicon Research EBITDA per Employee

The EBITDA per Employee of Rubicon Research (RUBICON.NS) as of Oct 15, 2026 is 3.12 M INR. In the previous year, EBITDA per Employee was 2.25 M INR — a change of 38.93% (higher).

EBITDA per Employee

3.12 MINR

YoY

38.93%

Last updated:

EBITDA per Employee of Rubicon Research is 2026 3.12 M INR. EBITDA per Employee of Rubicon Research was 2025 2.25 M INR. It decreases by 38.93% higher compared to the previous year.

The Rubicon Research EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2023
305,109.55 INR
Jan 1, 2024
1.56 M INR
Jan 1, 2025
2.25 M INR
Jan 1, 2026
3.12 M INR
The Rubicon Research EBITDA per Employee history
YEAREBITDA per EmployeeYoY
3.12 MINR+38.93%
2.25 MINR+43.80%
1.56 MINR+411.95%
305,109.55INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Rubicon Research Stock analysis

What does Rubicon Research do? Rubicon Research Ltd is a company based in Thane, India, with an employee count of 1141. It operates in the manufacturing and export of pharmaceutical formulations across various dosage forms and therapeutic areas. The company's portfolio includes oral solids, oral liquids, nasal, and topical dosage forms. Its services encompass intellectual property evaluation, product design, formulation and analytical research and development, technology transfer, dossier compilation, regulatory support, and clinical trials supplies. The company's products cover therapeutic areas such as Analgesics/Pain Management, CVS, CNS, Hypokalemia, Skeletal Muscle Relaxants, NRT, Gastrointestinal, Metabolic, Immunosuppressant, and others. Additional therapeutic areas include Antipyretic, Hormonal Products, Diuretic, Antimuscarinics, Oral Rehydration Therapy, Over the Counter products, and Respiratory. Rubicon Research Ltd is scheduled to go public with an IPO on October 16, 2025. The company's website is https://www.rubicon.co.in/. Rubicon Research is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rubicon Research stock

EBITDA per Employee of Rubicon Research is 3.12 M INR in 2026.

EBITDA per Employee of Rubicon Research changed from 2.25 M INR to 3.12 M INR, representing a 38.93% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Rubicon Research since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Rubicon Research historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — Rubicon Research

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Rubicon Research